CHIR-258, a Novel, Multitargeted Tyrosine Kinase Inhibitor for the Potential Treatment of T(4;14) Multiple Myeloma
Blood - United States
doi 10.1182/blood-2004-10-3913
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2005
Authors
Publisher
American Society of Hematology